IGFBP2 and glioma: Of the two Type 1 hits, MIIP (migration and invasion inhibitory protein) was initially identified in a yeast-two-hybrid screen as a binding partner for the insulin-like growth factor binding protein 2 (IGFBP2) and shown to inhibit glioma cell invasion [22].